ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2022 American Transplant Congress

    Telemedicine Implementation in Solid Organ Transplant (SOT) Clinics is Associated with Satisfaction Among Patients and Providers but Increased Burden on Staff

    C. W. Wang, N. Ha, M. Duarte, C. B. Sherman

    University of California, San Francisco, San Francisco, CA

    *Purpose: Telemedicine is an essential part of healthcare delivery and has grown exponentially during the COVID-19 pandemic. Data on optimal utilization and implementation of telemedicine…
  • 2022 American Transplant Congress

    Evaluation of Post-Transplant Angiotensin II Type 1 Receptor Antibodies, Donor-Derived Cell-Free DNA, and Rejection in Heart Transplant Recipients

    B. Agegnehu1, S. Sterling1, R. Winstead1, I. Tchoukina2

    1Pharmacy, VCU Health System, Richmond, VA, 2Advanced Heart Failure and Transplant Cardiology, VCU Health System, Richmond, VA

    *Purpose: There is limited evidence evaluating the relationship between angiotensin II type 1 receptor antibodies (AT1R-Abs), donor-derived cell-free DNA (dd-cfDNA), and rejection in heart transplant…
  • 2022 American Transplant Congress

    Effect of Covid-19 Vaccination on Markers of Rejection in Heart Transplant Recipients

    Z. Pieters1, E. Bruno1, S. Kim1, S. De Sirkar1, M. Thomas1, S. B. Sharmin2, M. Liebo1, A. Heroux1, N. Clark1, G. Reid1, S. Uprichard2, M. Yu1

    1Medicine, Loyola University Medical Center, Maywood, IL, 2Loyola University Chicago, Chicago, IL

    *Purpose: Heart transplant recipients have worse survival with COVID-19 than the general population, highlighting the importance of vaccination in these patients. The impact of vaccination…
  • 2022 American Transplant Congress

    Successful Outcome of Highly Sensitized Patients After Heart Transplantation Under RATG Regimen

    G. Esmailian, T. Singer-Englar, J. Patel, M. Kittleson, S. Kim, N. Patel, D. Chang, E. Kransdorf, F. Esmailian, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Highly sensitized patients (panel reactive antibody [PRA] ≥50%) are known to be at risk for poor outcome after heart transplantation (HTx). In our program,…
  • 2022 American Transplant Congress

    CoVID-19 Vaccine Efficacy in Heart Transplant Recipients, a Single Center Experience

    M. Yu1, S. B. Sharmin2, C. Joyce3, Z. Pieters1, S. DeSirkar1, M. Thomas1, S. Kim1, E. Bruno1, M. Liebo1, A. Heroux4, N. Clark1, G. Reid1, S. Uprichard2

    1Loyola University Medical Center, Maywood, IL, 2Microbiology and Immunology, Loyola University Chicago, Chicago, IL, 3Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, 4Loyola Univ Medical Ctr, Maywood, IL

    *Purpose: Transplant recipients have worse CoVID-19 survival compared to the general population, and thus are recommended to be vaccinated and boosted. Determinants of vaccination efficacy…
  • 2022 American Transplant Congress

    Cost-Effectiveness of Transplanting Hepatitis C Donor Hearts Into Hepatitis C Uninfected Recipients

    A. R. Gandhi1, A. E. Woolley2, L. R. Baden2, M. M. Givertz2, M. L. Jones1, J. Kim3, H. R. Mallidi2, M. R. Mehra2, A. M. Neilan1

    1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Harvard T.H. Chan School of Public Health, Boston, MA

    *Purpose: To examine the clinical impact and cost-effectiveness of hepatitis C viremic (HCV+) heart organ donation in the United States.*Methods: We used a microsimulation model…
  • 2022 American Transplant Congress

    Sex- and Insurance- Based Disparities in Listing for and Benefit from Simultaneous Heart-Kidney Transplant

    B. Wayda1, X. S. Cheng1, P. Garcia1, S. Sanoff2, L. M. McElroy2, K. K. Khush1

    1Stanford University School of Medicine, Stanford, CA, 2Duke University School of Medicine, Durham, NC

    *Purpose: Rates of simultaneous heart-kidney (SHK) transplant vary widely in the United States (US). Absent uniform eligibility criteria, sex and insurance status could influence patient…
  • 2022 American Transplant Congress

    Effects of Race, Previous CoV2 Exposure and the Length and Type of Maintenance Immunosuppression on Protective Immunity to COVID19 Vaccine in Solid Organ Transplant Recipients

    A. Choudhary1, M. Lerman2, S. Khan2, J. Hunt2, A. Nikaein3, D. Calianese1, E. Kalu2, D. K. Jaijyan4, W. Honnen1, A. Pinter1

    1PHRI, Rutgers University, Newark, NJ, 2Transplant, Medical City Dallas, Dallas, TX, 3Texas Speciality, Medical City Dallas, Dallas, TX, 4pHRI, Rutgers University, Newark, NJ

    *Purpose: The diverse factors affecting the vaccine induced neutralizing antibody response in solid organ transplant recipients and their immunity against CoV2 variants are needed to…
  • 2022 American Transplant Congress

    The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation

    M. Dela Cruz1, H. Lin2, E. Adler2, M. Khalid2, J. Boissiere2, G. Kim1, S. Pinney1, E. Pamer2, A. Nguyen1

    1Section of Cardiology, University of Chicago, Chicago, IL, 2Duchossois Family Institute, University of Chicago, Chicago, IL

    *Purpose: Given its potential impact on immune activation and systemic inflammation, we aim to investigate gut microbiome compositions and metabolites during critical illness in the…
  • 2022 American Transplant Congress

    Association Between Time in Therapeutic Range for Warfarin and Time in Therapeutic Range for Calcineurin Inhibitors in Patients That Received Left Ventricular Assist Devices as Bridge to Transplant

    G. Flajc1, X. Huang2, C. Minard2, M. Manson1, Z. Truman1

    1Baylor St. Luke's Medical Center, Houston, TX, 2Baylor College of Medicine, Houston, TX

    *Purpose: Medication nonadherence is a leading cause of avoidable graft failure post-transplant. The relationship between medication adherence in patients with left ventricular assist devices (LVADs)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences